4.7 Review

The National Data Bank for rheumatic diseases: a multi-registry rheumatic disease data bank

Journal

RHEUMATOLOGY
Volume 50, Issue 1, Pages 16-24

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/keq155

Keywords

NDB; Registry; Data Bank; National Data Bank for rheumatic diseases

Categories

Funding

  1. Bristol Myers Squibb
  2. UCB
  3. Pfizer

Ask authors/readers for more resources

The National Data Bank (NDB) for rheumatic diseases is a patient-based multi-disease, multi-purpose rheumatic disease registry that has been used primarily to study patients with RA, SLE, FM and OA. It enrols patients from the community, follows up with questionnaires and validates key patient data using medical records. Rheumatologist-written programs make NDB data immediately available to analysts. The NDB has been used to develop and validate diagnostic criteria, develop new questionnaires, describe illness and comorbid disease, assesses disease outcomes and the effect of therapeutic interventions, and measure costs and cost-effectiveness.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available